Sanchez V, Baumann A, Kromm F, Yergaliyev T, Brandt A, Scholda J
Mol Med. 2024; 30(1):181.
PMID: 39425011
PMC: 11488139.
DOI: 10.1186/s10020-024-00950-4.
Yoladi F, Burmaoglu E, Palabiyik S
Eurasian J Med. 2024; 55(1):82-90.
PMID: 39109811
PMC: 11075036.
DOI: 10.5152/eurasianjmed.2023.23345.
Huneault H, Ramirez Tovar A, Sanchez-Torres C, Welsh J, Vos M
Hepatol Commun. 2023; 7(11).
PMID: 37930128
PMC: 10629746.
DOI: 10.1097/HC9.0000000000000297.
Qiu F, Zeng R, Li D, Ye T, Xu W, Wang X
Heliyon. 2023; 9(9):e19359.
PMID: 37681138
PMC: 10481297.
DOI: 10.1016/j.heliyon.2023.e19359.
Wu S, Wang X, Xing W, Li F, Liang M, Li K
Front Med (Lausanne). 2023; 10:1160053.
PMID: 37035335
PMC: 10076546.
DOI: 10.3389/fmed.2023.1160053.
Hepatic PEMT Expression Decreases with Increasing NAFLD Severity.
Piras I, Raju A, Don J, Schork N, Gerhard G, DiStefano J
Int J Mol Sci. 2022; 23(16).
PMID: 36012560
PMC: 9409182.
DOI: 10.3390/ijms23169296.
Alcohol-Related Elevation of Liver Transaminase Is Associated With Gut Microbiota in Male.
Jiao M, Yan S, Shi Q, Liu Y, Li Y, Lv J
Front Med (Lausanne). 2022; 9:823898.
PMID: 35280887
PMC: 8904186.
DOI: 10.3389/fmed.2022.823898.
A mini-review of the rodent models for alcoholic liver disease: shortcomings, application, and future prospects.
Liu S, Du Y, Zeng T
Toxicol Res (Camb). 2021; 10(3):523-530.
PMID: 34141166
PMC: 8201549.
DOI: 10.1093/toxres/tfab042.
Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD - Reconciling the present with the past.
Ayonrinde O
JHEP Rep. 2021; 3(3):100261.
PMID: 34036255
PMC: 8135048.
DOI: 10.1016/j.jhepr.2021.100261.
Circulating trimethylamine-N-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease.
Flores-Guerrero J, Post A, van Dijk P, Connelly M, Garcia E, Navis G
Liver Int. 2021; 41(10):2371-2382.
PMID: 33993608
PMC: 8518486.
DOI: 10.1111/liv.14963.
The History of Alcoholic Liver Disease: From an Unrecognized Disease to One of the Most Frequent Diseases in Hepatology.
Seitz H, Neuman M
J Clin Med. 2021; 10(4).
PMID: 33669694
PMC: 7921942.
DOI: 10.3390/jcm10040858.
Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease.
Luukkonen P, Tukiainen T, Juuti A, Sammalkorpi H, Haridas P, Niemela O
JCI Insight. 2020; 5(5).
PMID: 32161197
PMC: 7141400.
DOI: 10.1172/jci.insight.132158.
Fatty Liver, Hepatitus, and Cirrhosis in Sub-Human Primates Fed Ethanol.
Tsukamoto H
Alcohol Health Res World. 2019; 19(1):42-43.
PMID: 31798089
PMC: 6875784.
Alcoholic liver disease: Utility of animal models.
Lamas-Paz A, Hao F, Nelson L, Vazquez M, Canals S, Gomez Del Moral M
World J Gastroenterol. 2018; 24(45):5063-5075.
PMID: 30568384
PMC: 6288648.
DOI: 10.3748/wjg.v24.i45.5063.
Chronic + binge alcohol exposure promotes inflammation and alters airway mechanics in the lung.
Poole L, Beier J, Torres-Gonzales E, Schlueter C, Hudson S, Artis A
Alcohol. 2018; 80:53-63.
PMID: 30445135
PMC: 6513731.
DOI: 10.1016/j.alcohol.2018.10.008.
Experimental models of liver fibrosis.
Crespo Yanguas S, Cogliati B, Willebrords J, Maes M, Colle I, Van den Bossche B
Arch Toxicol. 2015; 90(5):1025-1048.
PMID: 26047667
PMC: 4705434.
DOI: 10.1007/s00204-015-1543-4.
Build a better mouse model, and the world will beat a path to your door.
Arteel G
Hepatology. 2013; 58(5):1526-8.
PMID: 23813457
PMC: 4352948.
DOI: 10.1002/hep.26596.
Rodent models of alcoholic liver disease: of mice and men.
Brandon-Warner E, Schrum L, Schmidt C, McKillop I
Alcohol. 2012; 46(8):715-25.
PMID: 22960051
PMC: 3496818.
DOI: 10.1016/j.alcohol.2012.08.004.
Animal models of alcoholic liver disease.
Arteel G
Dig Dis. 2011; 28(6):729-36.
PMID: 21525757
PMC: 7065415.
DOI: 10.1159/000324280.
Mechanisms and cell signaling in alcoholic liver disease.
Beier J, McClain C
Biol Chem. 2010; 391(11):1249-64.
PMID: 20868231
PMC: 3755482.
DOI: 10.1515/BC.2010.137.
